ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB)

Q3 2019 13F Holders as of 9/30/2019

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 52.3M
Number of holders: 80
Total 13F shares, excl. options: 32.6M
Shares change: +188K
Total reported value, excl. options: $117M
Value change: +$1.02M
Number of buys: 30
Number of sells: -43
Price: $3.60

Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q3 2019

94 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q3 2019.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 32.6M shares of 52.3M outstanding shares and own 62.42% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.62M shares), Evermore Global Advisors, LLC (4.01M shares), BlackRock Inc. (3.69M shares), WELLINGTON MANAGEMENT GROUP LLP (3.58M shares), RENAISSANCE TECHNOLOGIES LLC (3.3M shares), VANGUARD GROUP INC (2.16M shares), DIMENSIONAL FUND ADVISORS LP (2.14M shares), ARIEL INVESTMENTS, LLC (1.03M shares), STATE STREET CORP (779K shares), and NORTHERN TRUST CORP (536K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.